Ignite Creation Date:
2024-05-06 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05063162
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2021-09-21
Brief Title:
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein MOG Antibody-associated Disease MOG-AD
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma